These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 15666660)

  • 1. The modern landscape of transfusion-related iatrogenic Creutzfeldt-Jakob disease and blood screening tests.
    Brown P; Cervenakova L
    Curr Opin Hematol; 2004 Sep; 11(5):351-6. PubMed ID: 15666660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advances in screening test development for transmissible spongiform encephalopathies.
    Cervenakova L; Brown P
    Expert Rev Anti Infect Ther; 2004 Dec; 2(6):873-80. PubMed ID: 15566331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of a test for its suitability in the diagnosis of variant Creutzfeldt-Jakob disease.
    Cooper JK; Andrews N; Ladhani K; Bujaki E; Minor PD
    Vox Sang; 2013 Oct; 105(3):196-204. PubMed ID: 23772892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pre-clinical diagnosis of transmissible spongiform encephalopathies using rapid tests.
    Grassi J
    Transfus Clin Biol; 2003 Feb; 10(1):19-22. PubMed ID: 12668183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can Creutzfeldt-Jakob disease be transmitted by transfusion?
    Brown P
    Curr Opin Hematol; 1995 Nov; 2(6):472-7. PubMed ID: 9372038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of variant Creutzfeldt-Jakob disease for safety of treatment with blood components: screening of lymphatic tissue is a potential tool for risk assessment.
    Sachse C; Groschup MH; Warzok R; Greinacher A
    Eur J Haematol; 2003 Jan; 70(1):11-6. PubMed ID: 12631254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proceedings of a consensus conference: the screening of blood donors for variant CJD.
    Blajchman MA; Goldman M; Webert KE; Vamvakas EC; Hannon J; Delage G
    Transfus Med Rev; 2004 Apr; 18(2):73-92. PubMed ID: 15067588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. alpha-Hemoglobin stabilizing protein is not a suitable marker for a screening test for variant Creutzfeldt-Jakob disease.
    Appleford NE; Wilson K; Houston F; Bruce LJ; Morrison A; Bishop M; Chalmers K; Miele G; Massey E; Prowse C; Manson J; Will RG; Clinton M; MacGregor I; Anstee DJ
    Transfusion; 2008 Aug; 48(8):1616-26. PubMed ID: 18503615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prion, from crazy cows to iatrogenic Creutzfeldt-Jakob disease. Which risk in laboratory or in hospital?].
    Paul J
    Pathol Biol (Paris); 1995 Feb; 43(2):114-20. PubMed ID: 7777380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Creutzfeldt-Jakob disease and the risk from blood or blood products.
    Will RG; Kimberlin RH
    Vox Sang; 1998; 75(3):178-80. PubMed ID: 9852403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variant Creutzfeldt-Jakob disease and blood transfusion.
    Turner ML
    Curr Opin Hematol; 2001 Nov; 8(6):372-9. PubMed ID: 11604578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Transmissible spongiform encephalopathies: Creutzfeldt-Jakob disease].
    Rabenau HF; Preiser W; Doerr HW
    Chirurg; 1998 May; 69(5):511-21. PubMed ID: 9653555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A new variant of Creutzfeldt-Jakob disease. Do we want development of a new epidemic?].
    Sande R; Tysnes OB
    Tidsskr Nor Laegeforen; 1997 Jan; 117(3):384-8. PubMed ID: 9064863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. vCJD screening and its implications for transfusion--strategies for the future?
    Turner ML
    Blood Coagul Fibrinolysis; 2003 Jun; 14 Suppl 1():S65-8. PubMed ID: 14567540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prions: properties, occurrence, modes of transmission and relevance for blood transfusion and blood derivatives.
    Yap PL; Leaver HA; Gillon J
    Vox Sang; 1998; 74 Suppl 2():131-4. PubMed ID: 9704435
    [No Abstract]   [Full Text] [Related]  

  • 16. [Creutzfeldt-Jakob disease: diagnosis, incidence, prevention and treatment].
    Croes EA; van Gool WA; Jansen GH; van Duijn CM
    Ned Tijdschr Geneeskd; 2002 Apr; 146(16):750-4. PubMed ID: 11998351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Creutzfeldt-Jakob disease: blood infectivity and screening tests.
    Brown P
    Semin Hematol; 2001 Oct; 38(4 Suppl 9):2-6. PubMed ID: 11685719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variant Creutzfeldt-Jacob disease - the availability of a screening test will be the beginning, not the end, of difficult transfusion-related issues.
    Sandler SG
    Curr Opin Hematol; 2006 Nov; 13(6):445-6. PubMed ID: 17053456
    [No Abstract]   [Full Text] [Related]  

  • 19. [Mad cow disease and the new variant of Creutzfeldt-Jakob disease].
    Pastoret PP
    Rev Med Liege; 2001 Aug; 56(8):567-71. PubMed ID: 11584442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue safety in view of CJD and variant CJD.
    Pauli G
    Cell Tissue Bank; 2005; 6(3):191-200. PubMed ID: 16151959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.